RTX Corp (RTX) Insider Transactions
Explore official ownership filings, with every record linked to its source.
RTX · RTX Corp
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-30Filed 2026-11-03 | Williams Dantaya MOfficer · EVP & Chief HR OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: | M Exercise / conversionStock Appreciation Right · Derivative | 17,000D | 0 | Direct | Form 4 ↗0001225208-26-008630 |
| 2026-10-30Filed 2026-11-03 | Williams Dantaya MOfficer · EVP & Chief HR OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: | S Sale (market/private)Common Stock · Non-derivative | 9,071D | 201.6951 | Direct | Form 4 ↗0001225208-26-008630 |
| 2026-10-30Filed 2026-11-03 | Williams Dantaya MOfficer · EVP & Chief HR OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: | D Other reported codeCommon Stock · Non-derivative | 7,929D | 201.62 | Direct | Form 4 ↗0001225208-26-008630 |
| 2026-10-30Filed 2026-11-03 | Williams Dantaya MOfficer · EVP & Chief HR OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 17,000A | 94.04 | Direct | Form 4 ↗0001225208-26-008630 |
| 2026-10-01Filed 2026-10-05 | Johnson Amy LOfficer · Senior VP and ControllerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit. F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025. References: F1, F2 | M Exercise / conversionRestricted Stock Units · Derivative | 84D | 0 | Direct | Form 4 ↗0001225208-26-008208 |
| 2026-10-01Filed 2026-10-05 | Johnson Amy LOfficer · Senior VP and ControllerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit. F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025. References: | F WithholdingCommon Stock · Non-derivative | 84D | 185.01 | Direct | Form 4 ↗0001225208-26-008208 |
| 2026-10-01Filed 2026-10-05 | Johnson Amy LOfficer · Senior VP and ControllerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit. F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 84A | 0 | Direct | Form 4 ↗0001225208-26-008208 |
| 2026-10-01Filed 2026-10-05 | DaSilva Kevin GOfficer · Senior VP and TreasurerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit. F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025. References: F1, F2 | M Exercise / conversionRestricted Stock Units · Derivative | 143D | 0 | Direct | Form 4 ↗0001225208-26-008207 |
| 2026-10-01Filed 2026-10-05 | DaSilva Kevin GOfficer · Senior VP and TreasurerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit. F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025. References: | F WithholdingCommon Stock · Non-derivative | 143D | 185.01 | Direct | Form 4 ↗0001225208-26-008207 |
| 2026-10-01Filed 2026-10-05 | DaSilva Kevin GOfficer · Senior VP and TreasurerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit. F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 143A | 0 | Direct | Form 4 ↗0001225208-26-008207 |
| 2026-08-18Filed 2026-08-19 | Maharajh RamsaranOfficer · EVP and General CounselFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $223.86 to $224.09 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request. F2 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: F2 | M Exercise / conversionStock Appreciation Right · Derivative | 20,069D | 0 | Direct | Form 4 ↗0001225208-26-007206 |
| 2026-08-18Filed 2026-08-19 | Maharajh RamsaranOfficer · EVP and General CounselFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $223.86 to $224.09 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request. F2 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 13,655D | 223.9153 | Direct | Form 4 ↗0001225208-26-007206 |
| 2026-08-18Filed 2026-08-19 | Maharajh RamsaranOfficer · EVP and General CounselFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $223.86 to $224.09 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request. F2 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: | D Other reported codeCommon Stock · Non-derivative | 6,414D | 224.07 | Direct | Form 4 ↗0001225208-26-007206 |
| 2026-08-18Filed 2026-08-19 | Maharajh RamsaranOfficer · EVP and General CounselFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $223.86 to $224.09 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request. F2 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: | M Exercise / conversionCommon Stock · Non-derivative | 20,069A | 71.62 | Direct | Form 4 ↗0001225208-26-007206 |
| 2026-07-28Filed 2026-07-28 | DaSilva Kevin GOfficer · Senior VP and TreasurerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | S Sale (market/private)Common Stock · Non-derivative | 2,250D | 216.932 | Direct | Form 4 ↗0001225208-26-006771 |
| 2026-07-27Filed 2026-07-28 | Atkinson Tracy ADirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | S Sale (market/private)Common Stock · Non-derivative | 2,295D | 218.0497 | Direct | Form 4 ↗0001225208-26-006772 |
| 2026-07-24Filed 2026-07-28 | Brunk Troy DOfficer · President, Collins AerospaceFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: F1 | M Exercise / conversionStock Appreciation Right · Derivative | 12,600D | 0 | Direct | Form 4 ↗0001225208-26-006773 |
| 2026-07-24Filed 2026-07-28 | Brunk Troy DOfficer · President, Collins AerospaceFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: | S Sale (market/private)Common Stock · Non-derivative | 6,746D | 210.2 | Direct | Form 4 ↗0001225208-26-006773 |
| 2026-07-24Filed 2026-07-28 | Brunk Troy DOfficer · President, Collins AerospaceFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: | D Other reported codeCommon Stock · Non-derivative | 5,854D | 210.17 | Direct | Form 4 ↗0001225208-26-006773 |
| 2026-07-24Filed 2026-07-28 | Brunk Troy DOfficer · President, Collins AerospaceFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: | S Sale (market/private)Common Stock · Non-derivative | 1,811D | 210.645 | Direct | Form 4 ↗0001225208-26-006773 |
| 2026-07-24Filed 2026-07-28 | Brunk Troy DOfficer · President, Collins AerospaceFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. References: | M Exercise / conversionCommon Stock · Non-derivative | 12,600A | 97.65 | Direct | Form 4 ↗0001225208-26-006773 |
| 2026-07-24Filed 2026-07-28 | DaSilva Kevin GOfficer · Senior VP and TreasurerFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | S Sale (market/private)Common Stock · Non-derivative | 4,760D | 213.62 | Direct | Form 4 ↗0001225208-26-006771 |
| 2026-07-01Filed 2026-07-06 | JASPER PHILIP JOfficer · President, RaytheonFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each Restricted Stock Unit (RSU), including dividend equivalents that accrue during the vesting period, represents a contingent right to receive one share of RTX Common Stock. These RSUs vest on the third anniversary of the date of grant. References: F1 | A Award / grantRestricted Stock Units · Derivative | 20,860A | 0 | Direct | Form 4 ↗0001225208-26-006517 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.